EGM
RARE icon

Engineers Gate Manager’s Ultragenyx Pharmaceutical RARE Stock Holding History

Engineers Gate Manager’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Sell
48,557
-40,898
-46% -$1.02M 0.02% 798
2026
Q1 		$1.87M Buy
89,455
+12,753
+17% +$287K 0.02% 735
2025
Q4 		$1.76M Buy
76,702
+43,579
+132% +$1.43M 0.02% 753
2025
Q3 		$996K Sell
33,123
-27,836
-46% -$835K 0.01% 1157
2025
Q2 		$2.22M Sell
60,959
-2,456
-4% -$88.5K 0.03% 687
2025
Q1 		$2.3M Buy
63,415
+28,161
+80% +$1.17M 0.04% 635
2024
Q4 		$1.48M Buy
35,254
+23,679
+205% +$1.17M 0.03% 777
2024
Q3 		$643K Sell
11,575
-2,789
-19% -$142K 0.01% 1261
2024
Q2 		$590K Sell
14,364
-65,505
-82% -$2.8M 0.01% 1147
2024
Q1 		$3.73M Buy
79,869
+70,917
+792% +$3.35M 0.1% 273
2023
Q4 		$428K Sell
8,952
-8,604
-49% -$334K 0.01% 1262
2023
Q3 		$626K Sell
17,556
-15,370
-47% -$609K 0.02% 953
2023
Q2 		$1.52M Buy
32,926
+16,853
+105% +$782K 0.06% 471
2023
Q1 		$645K Buy
+16,073
New +$690K 0.03% 849
2022
Q4 		– Sell
-35,788
Closed -$1.48M – 1971
2022
Q3 		$1.48M Buy
+35,788
New +$1.84M 0.09% 275
2021
Q3 		– Sell
-21,316
Closed -$2.03M – 1918
2021
Q2 		$2.03M Buy
+21,316
New +$2.22M 0.13% 177
2021
Q1 		– Sell
-10,677
Closed -$1.48M – 2073
2020
Q4 		$1.48M Buy
+10,677
New +$1.27M 0.06% 433

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Engineers Gate Manager's RARE Position: Q2 2026 in Review

Engineers Gate Manager reduced its Ultragenyx Pharmaceutical (RARE) stake by 46% in Q2 2026, selling an estimated $1.02M and leaving 48,557 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #798.

Engineers Gate Manager first reported a position in RARE in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.73M in Q1 2024. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Engineers Gate Manager held 48,557 shares of Ultragenyx Pharmaceutical worth $1.62M as of Q2 2026.
  • Engineers Gate Manager sold 40,898 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.02M.
  • Ultragenyx Pharmaceutical made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #798 holding.
  • Engineers Gate Manager first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 17 quarters since.
  • Engineers Gate Manager's Ultragenyx Pharmaceutical position peaked at $3.73M in Q1 2024.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.